Skip to main content
. 2017 Mar 31;8(23):37239–37249. doi: 10.18632/oncotarget.16744

Figure 1. Schematic representation of the study population and the study plan.

Figure 1

ET: Essential Thrombocythemia; PV: Polycythemia Vera; MF: primary Myelofibrosis; MPN NOS: Myeloproliferative Neoplasm Not Otherwise Specified; MPDs: Myeloproliferative Diseases.